Evaluating the Virology and Evolution of Seasonal Human Coronaviruses Associated with the Common Cold in the COVID-19 Era
- PMID: 36838410
- PMCID: PMC9961755
- DOI: 10.3390/microorganisms11020445
Evaluating the Virology and Evolution of Seasonal Human Coronaviruses Associated with the Common Cold in the COVID-19 Era
Abstract
Approximately 15-30% of all cases of the common cold are due to human coronavirus infections. More recently, the emergence of the more severe respiratory coronaviruses, SARS-CoV and MERS-CoV, have highlighted the increased pathogenic potential of emergent coronaviruses. Lastly, the current emergence of SARS-CoV-2 has demonstrated not only the potential for significant disease caused by emerging coronaviruses, but also the capacity of novel coronaviruses to promote pandemic spread. Largely driven by the global response to the COVID-19 pandemic, significant research in coronavirus biology has led to advances in our understanding of these viruses. In this review, we evaluate the virology, emergence, and evolution of the four endemic coronaviruses associated with the common cold, their relationship to pandemic SARS-CoV-2, and discuss the potential for future emergent human coronaviruses.
Keywords: COVID-19; common cold; coronavirus.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2.Curr Pharm Des. 2020;26(41):5286-5292. doi: 10.2174/1381612826666200821120409. Curr Pharm Des. 2020. PMID: 32954998 Review.
-
The emergence of Covid-19: evolution from endemic to pandemic.J Immunoassay Immunochem. 2022 Jan 2;43(1):22-32. doi: 10.1080/15321819.2021.1991947. Epub 2021 Oct 21. J Immunoassay Immunochem. 2022. PMID: 34672900 Review.
-
Coronavirus, the King Who Wanted More Than a Crown: From Common to the Highly Pathogenic SARS-CoV-2, Is the Key in the Accessory Genes?Front Microbiol. 2021 Jul 14;12:682603. doi: 10.3389/fmicb.2021.682603. eCollection 2021. Front Microbiol. 2021. PMID: 34335504 Free PMC article. Review.
-
The Molecular Virology of Coronaviruses with Special Reference to SARS-CoV-2.Adv Exp Med Biol. 2021;1352:15-31. doi: 10.1007/978-3-030-85109-5_2. Adv Exp Med Biol. 2021. PMID: 35132592 Review.
-
Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight.Acta Pharm Sin B. 2020 Jul;10(7):1175-1191. doi: 10.1016/j.apsb.2020.05.009. Epub 2020 May 30. Acta Pharm Sin B. 2020. PMID: 32834948 Free PMC article. Review.
Cited by
-
Seasonality of endemic COVID-19.mBio. 2023 Dec 19;14(6):e0142623. doi: 10.1128/mbio.01426-23. Epub 2023 Nov 8. mBio. 2023. PMID: 37937979 Free PMC article.
-
Revisiting Pathogen Exploitation of Clathrin-Independent Endocytosis: Mechanisms and Implications.Cells. 2025 May 16;14(10):731. doi: 10.3390/cells14100731. Cells. 2025. PMID: 40422234 Free PMC article. Review.
-
Discovery of a nasal spray steroid, tixocortol, as an inhibitor of SARS-CoV-2 main protease and viral replication.RSC Med Chem. 2024 Sep 27;15(12):4193-205. doi: 10.1039/d4md00454j. Online ahead of print. RSC Med Chem. 2024. PMID: 39371432 Free PMC article.
-
Arctigenin from Forsythia viridissima Fruit Inhibits the Replication of Human Coronavirus.Int J Mol Sci. 2024 Jul 4;25(13):7363. doi: 10.3390/ijms25137363. Int J Mol Sci. 2024. PMID: 39000469 Free PMC article.
-
Luteolin-7-O-glucoside from Elsholtzia ciliata extract inhibits the replication of coronavirus.PLoS One. 2025 Jun 3;20(6):e0325371. doi: 10.1371/journal.pone.0325371. eCollection 2025. PLoS One. 2025. PMID: 40460336 Free PMC article.
References
-
- Liu D.X., Liang J.Q., Fung T.S. Human Coronavirus-229E, -OC43, -NL63, and -HKU1 (Coronaviridae) Encycl. Virol. 2021;2:428–440. doi: 10.1016/B978-0-12-809633-8.21501-X. - DOI
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous